Your session is about to expire
← Back to Search
POST Facilitation for Post-Traumatic Stress Disorder (POST-RCT Trial)
POST-RCT Trial Summary
This trial will study the effects of a Physician Orders for Scope of Treatment (POST) Facilitation in a population of older adults who qualify for it, including those with normal cognition and those with Alzheimer's Disease and related disorders.
POST-RCT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPOST-RCT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.POST-RCT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 65 years old or older.I am 65 years old or older.You have one of the following conditions or scores that indicate a higher risk of mortality:
- Gagne Mortality Index score of 7 or higher, which means a 30% risk of death
- Medicare Criteria for Hospice Admission: Functional Assessment Staging Tool (FAST) Index of 7c or higher, along with one or more other health conditions, for advanced Alzheimer's disease and related dementia
- Seattle Heart Failure Model score indicating a 30% or higher risk of death within one year for congestive heart failure
- Eastern Cooperative Oncology Group (ECOG) performance status indicating impaired performance for metastatic cancer
- Liu Comorbidity Index score of 10 or higher for End Stage Renal Disease
- BARC Index for chronic obstructive pulmonary disease (COPD) indicating a high-risk group based on blood results, age, respiratory variables, and comorbidities
- Model for End Stage Liver Disease (MELD) Index (specific to liver disease)My daily activities are limited due to my cancer.I can make my own health decisions or have someone who can.You have a high risk of dying based on a score called Gagne Mortality Index which is 7 or higher.I can make my own health decisions or have someone who can.You have end-stage renal disease.I do not have any current severe illnesses.
- Group 1: Intervention (POST Facilitation)
- Group 2: Attention Control (Home Safety Evaluation)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants has this clinical trial recruited thus far?
"Affirmative. According to the information on clinicaltrials.gov, this medical experiment is currently seeking participants and was originally posted on May 11th 2020 with its most recent update occurring April 15th 2022. The trial seeks a total of 876 patients at 3 distinct sites."
Is enrollment in this research study currently available?
"According to the information held on clinicaltrials.gov, this trial is still accepting participants; it was initially posted on May 11th 2020 and has been altered as recently as April 15th 2022."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Most responsive sites:
- IU Health Methodist Hospital: < 24 hours
Typically responds via
Average response time
- < 1 Day
Share this study with friends
Copy Link
Messenger